Back to Search
Start Over
Impaired Luminal Control of Intestinal Macrophage Maturation in Patients With Ulcerative Colitis During RemissionSummary
- Source :
- Cellular and Molecular Gastroenterology and Hepatology, Vol 12, Iss 4, Pp 1415-1432 (2021), Cellular and Molecular Gastroenterology and Hepatology
- Publication Year :
- 2021
- Publisher :
- Elsevier, 2021.
-
Abstract
- Background & Aims Intestinal macrophages adopt a hyporesponsive phenotype through education by local signals. Lack of proper macrophage maturation in patients with ulcerative colitis (UC) in remission may initiate gut inflammation. The aim, therefore, was to determine the effects of fecal luminal factors derived from healthy donors and UC patients in remission on macrophage phenotype and function. Methods Fecal supernatants (FS) were extracted from fecal samples of healthy subjects and UC patients in remission. Monocytes were matured into macrophages in the presence of granulocyte-macrophage colony-stimulating factor without/with FS, stimulated with lipopolysaccharide, and macrophage phenotype and function were assessed. Fecal metabolomic profiles were analyzed by gas-chromatography/mass-spectrometry. Results Fecal luminal factors derived from healthy donors were effective in down-regulating Toll-like receptor signaling, cytokine signaling, and antigen presentation in macrophages. Fecal luminal factors derived from UC patients in remission were less potent in inducing lipopolysaccharide hyporesponsiveness and modulating expression of genes involved in macrophage cytokine and Toll-like receptor signaling pathways. Although phagocytic and bactericidal abilities of macrophages were not affected by FS treatment, healthy FS-treated macrophages showed a greater ability to suppress cluster of differentiation 4+ T-cell activation and interferon γ secretion compared with UC remission FS-treated counterparts. Furthermore, metabolomic analysis showed differential fecal metabolite composition for healthy donors and UC patients in remission. Conclusions Our data indicate that UC patients in remission lack luminal signals able to condition macrophages toward a hyporesponsive and tolerogenic phenotype, which may contribute to their persistent vulnerability to relapse.<br />Graphical abstract
- Subjects :
- Lipopolysaccharides
0301 basic medicine
Lipopolysaccharide
medicine.medical_treatment
FLA, flagella
TNF
RC799-869
FS, fecal supernatant
Monocytes
Feces
chemistry.chemical_compound
0302 clinical medicine
CXCL, C-X-C motif chemokine ligand
LP, lamina propria
Macrophage
Intestinal Mucosa
Original Research
TNF, tumor necrosis factor
IBD, inflammatory bowel disease
PGN, peptidoglycan
Toll-Like Receptors
Gastroenterology
Disease Management
ELISA, enzyme-linked immunosorbent assay
Diseases of the digestive system. Gastroenterology
Ulcerative colitis
Phenotype
M1MQ, M1 (proinflammatory) macrophage
Cytokine
SCFA, short-chain fatty acid
Metabolome
Cytokines
LPS, lipopolysaccharide
030211 gastroenterology & hepatology
Tumor necrosis factor alpha
Disease Susceptibility
Inflammation Mediators
GM-CSF, granulocyte-macrophage colony-stimulating factor
Signal Transduction
TLR, Toll-like receptor
CD, cluster of differentiation
Antigen presentation
GC-MS/MS, gas chromatography coupled to a tandem mass spectrometer
IFNγ, interferon γ
ODN, oligodeoxynucleotides
Immunophenotyping
03 medical and health sciences
Phagocytosis
medicine
Humans
Metabolomics
Ulcerative Colitis
Th, T-helper
PCA, principal component analysis
Hepatology
Cluster of differentiation
business.industry
Macrophages
Macrophage Activation
medicine.disease
IL, interleukin
UC, ulcerative colitis
030104 developmental biology
Gene Expression Regulation
chemistry
Case-Control Studies
Immunology
Colitis, Ulcerative
business
Biomarkers
TLR Signaling
Subjects
Details
- Language :
- English
- Volume :
- 12
- Issue :
- 4
- Database :
- OpenAIRE
- Journal :
- Cellular and Molecular Gastroenterology and Hepatology
- Accession number :
- edsair.doi.dedup.....32ce8b670ac92e77145e76a5dcc8b14f